OR WAIT null SECS
© 2022 MJH Life Sciences and Pharmaceutical Executive. All rights reserved.
© 2022 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
Julian Upton is Pharmaceutical Executive’s European and Online Editor. He can be reached at email@example.com
Biohaven CEO Vlad Coric talks to Pharm Exec about NURTEC ODT’s swift and seismic impact on the migraine market.
Closing the gaps in complex therapy data remains a hurdle, but “getting clever” with AI can offer a path forward.
How Gilead readied remdesivir for the COVID challenge.
How the UK is making progress in this hi-tech field.
Looking Back at 1997–1999.
Amgen is collaborating on two digital health initiatives aimed at improving heart failure care and rehabilitation.